The present study aimed to investigate whether the polymorphisms in the TSLPR gene are associated with atopic and asthmatic disease in the Korean population. We identified eleven single nucleotide polymorphisms (SNPs) and two variation sites in the TSLPR gene, including the promoter region. The genotype and allele frequencies of g.33G＞C of the TSLPR gene in asthma patients were significantly different from the respective frequencies of the control group (P = 0.006 and 0.003, respectively). Our additional analysis showed that the genotype and allele frequencies of the g.33G＞C and g.19646A＞G of the TSLPR gene were significantly associated in the atopic asthma patients rather than in the non-atopic asthma patients (genotype frequencies; P = 0.0001 and 0.0003 respectively, allele frequencies; P = 0.0005 and 0.0001 in that order). Our results suggest that the SNPs of the TSLPR gene could be associated with the susceptibility to atopic asthma in the Korean population. [BMB reports 2010; 43(7): 499-505]
INTRODUCTION
Allergic diseases such as asthma, allergic rhinitis and atopic dermatitis are usually due to an excessive immune response to certain antigens called allergens. Asthma is one of the most common multi-complex disorders and this is triggered by a genetic predisposition and environmental factors (1) . This disorder is characterized by reversible airflow obstruction and airway inflammation, and persistent airway hyper-reactivity (AHR) and airway remodeling (2) . Unlike other inflammatory diseases, the asthmatic inflammatory process is characterized by the predominant secretion of interleukin (IL)-4 and IL-5 by T-helper lymphocytes type 2 (Th2) and immunoglobulin (Ig)E synthesis. IgE mediates the early and late asthmatic responses that induce of lung eosinophil infiltration and Th2 cell cytokine production (3) .
Thymic stromal lymphopoietin (TSLP) has been proposed to signal through a heterodimeric receptor complex, which is composed of the TSLP receptor (TSLPR; also known as CRLF2) and the IL-7R alpha chain (4, 5) . Human TSLP is involved in dendritic cell maturation (6, 7) and it is produced by epithelial cells, stromal cells and mast cells. The single nucleotide polymorphisms (SNPs) of TSLP were associated with the susceptibility to allergic rhinitis (8) . The human TSLPR located in the Xp22.3 and Yp11.3 regions has been identified from a human T lymphocyte and dendritic cell (DC) cDNA library (9, 10) . TSLPR contains two fibronectin type III-like domains, four conserved cysteine residues and a WSXWS (Trp-Ser-X-Trp-Ser) box-like motif that is typical for type I cytokine receptors. The C-terminal intracellular region contains a membrane-proximal Box 1 motif, which also functions as a putative binding site for signal transduction molecules (9, 10) . The TSLPR knockout mice have normal numbers of lymphocytes, but the TSLPR/γc double knockout mice display a greater lymphoid defect than the γc KO mice (11) . Leonard and coworkers have also reported that these mice exhibit strong Th1 responses with high levels of IL-12, interferon-γ and IgG2a, but low levels of IL-4, IL-5, IL-10, IL-13 and IgE. TSLPR knockout mice fail to develop an inflammatory lung response to inhaled antigen unless they are supplemented with wild-type CD4 + T cells (12) . These results indicated that TSLPR plays an important role in the development of inflammatory and/or allergic responses. Shi and coworkers have recently suggested that the local application of anti-TSLPR prevented Th2-mediated airway inflammation by regulating the function of DCs, and this might be exploited to develop novel treatments for asthma (13) .
Although TSLPR is one of the crucial candidate genes for the development of allergic responses and the differentiation of T cells, any correlation between the SNPs of TSLPR and the individual susceptibility to asthma has not been demonstrated. In an attempt to understand the genetic influences of TSLPR on asthma, we have identified the possible variation sites and SNPs through the eight exons and their boundary introns sequences of TSLPR, including the ~1.9 kb promoter regions. http://bmbreports.org To determine whether these TSLPR SNPs are associated with the susceptibility to asthma, we analyzed the frequencies of the TSLPR SNPs on the genomic DNAs that were isolated from asthma patients and healthy controls. We further investigated the relationships between these polymorphisms and the total serum IgE levels, the peripheral blood eosinophil counts and the forced vital capacity (FVC) or forced expiratory volume in 1 second (FEV1) in asthma patients. Finally, we calculated the haplotype frequencies that were constructed by these SNPs in both groups.
RESULTS
The human TSLPR gene is located on chromosome Xp22.3 and Yp11.3, and it consists of seven (NM_001012288.1, isoform 2) or eight exons (NM_022148.2, isoform 1). We examined the expression pattern of TSLPR in 13 normal human tissues and peripheral leukocytes. The expression level of TSLPR mRNA was the highest in the ovary, pancreas and lung, yet that in brain and skeletal muscle was not detected (Fig. 1A) .
To determine the possible variation sites in the entire coding regions and their boundary introns sequences of the TSLPR isoform 1, including ~1.9 kb promoter regions, we first scanned the genomic DNAs isolated from 24 unrelated asthma patients and 24 healthy controls with using a direct sequencing method. We identified eleven SNPs and two variation sites, g.-1446A＞C (rs9780560) and g. (Fig. 1B) . While the g.33G＞C, g.21869T＞C, g.21884G＞A and g.21995T＞C polymorphisms located in the coding region were synonymous SNPs (Ala11Ala, Pro308Pro, Val313Val and Gly350Gly, respectively) in isoform 1, the amino acids of g.19646A＞G were substituted to Lys258Arg (K258R) in isoform 1. In the isoform 2 of TSLPR, the amino acid of g.19646A＞G SNPs was substituted to Lys146Arg (K146R). The linkage disequilibrium (LD) coefficients (|D'|) between all the SNP pairs were calculated, and we found the absolute LD (|D'| = 1 and r 2 = 1) between g.16196C＞A and g.16197C＞T, and between g.21869T＞ C and g.22129T＞C (data not shown). Among the identified polymorphisms, six SNPs (g.-43T＞C, g.33G＞C, g.19646A＞G, g.21869T＞C, g.21884G＞A and g.21995T＞C) were selected for large sample genotyping based on their locations and LD.
To determine whether the TSLPR SNPs are associated with the susceptibility of asthma, the genotypes of the TSLPR SNPs were analyzed by the single-base extension (SBE), high resolution melting (HRM) or TaqMan probe method. The genotypes and allele frequencies were compared between the asthma patients and the healthy controls. All the genotype frequencies were in Hardy-Weinberg equilibrium (HWE), except for the g.-43T＞C in the healthy controls and the g.19646A＞G in the asthma patients (data not shown). The genotype and allele frequencies of g.-43T＞C, g.19646A＞G, g.21869T＞C, g.21884G＞A and g.21995T＞C were not significantly different between the asthma patients and healthy controls. However, the genotype and allele frequencies of the g.33G＞ C of the TSLPR in the asthma patients were significantly different from the respective frequencies of the control group (P = 0.006 and 0.003, respectively, Table 1 ). We further analyzed the genotype and allele frequencies of the atopic asthma patients, the non-atopic asthma patients and the healthy controls (Table 1 ). In the atopic asthma patients rather than non-atopic asthma patients, the genotype and allele frequencies of the g.33G＞C as well as those of the g.19646A＞G were significantly different from the respective frequencies of the healthy controls group (genotype frequencies; P = 0.0001 and 0.0003 respectively, allele frequencies; P = 0.0005 and 0.0001 in that order). These results strongly suggest that the SNPs of the TSLPR gene could be associated with the susceptibility to atopic disease (Table 1) .
We further investigated the relationships between the SNPs http://bmbreports.org BMB reports Table. of TSLPR and the total serum IgE levels or the peripheral blood eosinophil counts in the asthma patients ( Table 2 ). The polymorphisms of TSLPR in the asthma patients were shown to have no significant association with the levels of total serum IgE and the peripheral blood eosinophil counts. We also investigated the relationships between the SNPs of TSLPR and the FVC or FEV1 in asthma patients. However, those also had no significant association (Supplementary Table 3 ). Finally, we estimated the haplotype frequencies of the block 1 (g.-43T＞C and g.33G＞C) and the block 2 (g.21869T＞C and g.21884G＞A) of the TSLPR gene between the healthy controls and the asthma patients (Table 3) . Although the minor haplotype (TG) frequency was somewhat different in the block 1 of the asthma patients, as compared to that of the healthy controls (P = 0.001), the major haplotypes' (frequency ＞ 0.05) distributions in block 1 and block 2 were not significant difference between the asthma patients and the healthy controls. These results suggest that the haplotypes of the TSLPR polymorphisms are not associated with asthma susceptibility.
DISCUSSION
Asthma is a multi-factorial inflammatory condition that's often associated with bronchial hyper-reactivity and atopy. Asthma is triggered by the genetic predisposition and environmental factors. In this study, we evaluated the associations between the TSLPR polymorphisms and the susceptibility to asthma.
The expression levels of TSLPR mRNA, as assessed by northern blot analysis, have been differently reported. Tonozuka et al. reported that TSLPR mRNA was expressed in liver, kidney, http://bmbreports.org Values were analyzed by permutation P value.
heart and skeletal muscle (9), while Zhang et al. showed that it was restrictedly expressed in spleen and peripheral blood leukocytes, and it was undetectable in thymus, liver, kidney, heart, skeletal muscle, brain, small intestine, placenta, lung and colon tissue (10) . In this study, we showed that the expressed levels of TSLPR mRNA by RT-PCR were highest in ovary, pancreas and lung, and they were only barely detected in kidney, heart, thymus and testis, while they were not detected in brain and skeletal muscle (Fig. 1A) .
In this study, we identified eleven SNPs, including six novel SNPs and two novel variation sites in TSLPR (Fig. 1B) , and we analyzed the genotype of these SNPs in asthma patients and healthy controls. The genotype and allele frequencies of the g.33G＞C of TSLPR in asthma patients were significantly different from those in the controls group (Table 1 ). This result suggests that the g.33G＞C polymorphism of TSLPR might be associated with the susceptibility to asthma. Our additional analysis of the genotype and allele frequencies between the atopic asthma or non-atopic asthma patients and the healthy controls showed that the genotype and allele frequencies of the g.33G＞C and g.19646A＞G were significantly associated in the atopic asthma patients rather than in the non-atopic asthma patients (Table 1) . These results strongly suggest that the SNPs of TSLPR could be associated with the susceptibility to atopic asthma. Interestingly, the amino acid of g.19646A＞ G was substituted to Lys258Arg and Lys146Arg in isoform 1 and 2, respectively, while the g.33G＞C was the synonymous SNP (Ala11Ala). Generally, synonymous variations affect mRNA stability, mRNA secondary structure and synthesis of the receptor and it can have effects of potential pathophysiological importance (14, 15) . These results and the LD block of TSLPR led to us think that the g.33G＞C and g.19646A＞G of TSLPR could be associated with the susceptibility to atopic disease with and without the change of amino acid, respectively.
Large numbers of eosinophils are accumulated in the lungs of asthmatic patients and they are believed to be essential in phagocytosis as well as in the allergic and inflammatory reactions of asthma. We previously reported that the SNPs or variations of the Tim-1 and IL-27 gene are associated with the susceptibility to asthma in a Korean population (16, 17) as well that the SNP of Eotaxin-3 is associated with the total IgE level in the serum of asthma patients (18) . However, our present study revealed that the SNPs of the TSLPR gene in asthma patients are not closely associated with the level of total serum IgE, the peripheral blood eosinophil counts (Table 2) , the FVC and the FEV1 (Supplementary Table 3) . Probably, the level of IgE and accumulation of eosinophil in chronic asthma patients come out of multiple physiological alterations that eventually leads to a late stage of asthmatic symptoms.
In conclusion, the results of this study suggest that TSLPR might be a candidate gene that is associated with the pathogenesis of atopic asthma, although we cannot rule out the possibility that multiple genetic alterations also lead to the aggravation of atopic disease, including asthma. Our results suggest that these polymorphisms are possibly correlated with the susceptibility to atopic or asthmatic disease.
MATERIALS AND METHODS

Patients and DNA samples
The DNA samples used in this study were provided by the Biobank of Wonkwang University Hospital, which is a member of the National Biobank of Korea and this Biobank is supported by the Ministry of Health, Welfare and Family Affairs. On the basis of approval and informed consent from the institutional review board, we obtained the genomic DNAs from 405 asthma patients and 570 healthy controls. The clinical parameters of the study subjects are summarized in Supplementary Table 1 . Genomic DNA was extracted from the leukocytes of the peripheral blood by a standard phenol-chloroform method or by using a Genomic DNA Extraction kit (iNtRON Biotechnology, Korea) according to the manufacturer's directions. Asthma was diagnosed in reference to the criteria of the American Thoracic Society (19) . The blood eosinophil counts and total serum IgE levels in the asthma patients were measured using a Coulter GenSTM Hematology Analyzer (Florida, USA) and a Roche COBAS-CORE II (Roche Diagnostics, Basal, Switzerland), respectively. All the subjects used in this study were Korean who lived in the same area.
Polymerase chain reaction (PCR) and sequencing analysis
The entire coding regions of the TSLPR, including the 1.9 kb promoter regions, were partially amplified with using eight primer pairs (Supplementary Table 2 Table 2 ) were used as sequencing primers. An additional two primers were employed for the sequencing of the TSLPR promoter regions (Supplementary Table 2 ). The SNPs of TSLPR were detected by sequence analysis that was based on the reference sequence of human chromosome X clone RP13-440N7.
mRNA expression level
The expression assay for TSLPR mRNA was performed using the cDNAs obtained from various human tissues and peripheral blood cells (Clontech, USA). Approximately 1 μg of total RNA was used in the first-strand cDNA synthesis with using a sequence specific primer and M-MLV reverse transcriptase (Bioneer, Korea) for reverse transcription-polymerase chain reaction (RT-PCR). The PCR samples were prepared in a 20 μl reaction volume containing 50 ng cDNA, 10x buffer 2 μl, 10 mM dNTP 0.5 μl, EF-taq 0.2 U (Solgent, Korea) and 0.5 μM of each primer (Supplementary Table 2 
HRM
Genotype analysis for g.-43T＞C, g.19646A＞G and g.21995T＞ C of the TSLPR gene was performed by HRM analysis. The 10 μl reaction mixture was made up using 1× QuantiTect Probe PCR Kit (Qiagen, Chatsworth, USA) and this consisted of 50 ng of genomic DNA, 100 nM of each primer (Supplementary Table 1 Table 1 ). The SBE reaction mix was prepared according to the previously described method (21) .
Genotype analysis by Taq-Man probe
The Taq-man assay probes for g.33G＞C and g.21869T＞C were designed by Integrated DNA Technologies (IDT, USA) and Operon Biotechnology (USA). FAM-fluorescence dye was attached to the TSLPR-1G, TSLPR-2T probe and the HEX-fluorescence dye was attached to the TSLPR-1C, TSLPR-2C probe (Supplementary Table 1 
Statistic analysis
The asthma patients and controls were compared using casecontrol association analysis. χ 2 tests were employed to estimate the HWE. Pair-wise comparison of the biallelic loci was employed for the analyses of LD. The haplotype frequencies of TSLPR for multiple loci were estimated using the expectation maximization (EM) algorithm with SNPAlyze software (DYNACOM, Yokohama, Japan). Logistic regression analyses (SPSS 11.5) were used to calculate the odds ratios (with the 95% confidence intervals). The ANOVA method was applied to define the IgE levels and the peripheral blood eosinophils counts of each genotype from the individual asthma patients. A P-value of less than 0.05 was considered to indicate statistical significance.
